Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayvon Modjarrad

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Scientific Reports|August 31, 2021
A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemicSimon Pollett, Matthew A Conte, Mark Sanborn, et al.
Ebiomedicine|September 18, 2024
Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trialAnke Pagnon, Christophe Carre, Marion Aguirre, et al.
Vaccine|February 4, 2018
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristicsJohan Vekemans, Vasee Moorthy, Brigitta Giersing, et al.
Vaccines|July 27, 2024
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 TrialJuleen Gayed, Vishva Bangad, Xia Xu, et al.
Journal of Immunological Methods|October 6, 2020
A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulinsMélanie Merbah, Suzanne Wollen-Roberts, Zhanna Shubin, et al.
Emerging Infectious Diseases|July 21, 2016
Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015Jean-Louis Excler, Christopher J Delvecchio, Ryan E Wiley, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2020
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variantsBethany Dearlove, Eric Lewitus, Hongjun Bai, et al.
Journal of Virology|May 26, 2017
Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater <i>In Vivo</i> Protection than the Murine Precursor of PalivizumabMin Zhao, Zi-Zheng Zheng, Man Chen, et al.
Epidemics|June 2, 2023
Community incidence patterns drive the risk of SARS-CoV-2 outbreaks and alter intervention impacts in a high-risk institutional settingSean M Moore, Guido España, T Alex Perkins, et al.
Plos Computational Biology|October 7, 2022
Prioritizing interventions for preventing COVID-19 outbreaks in military basic trainingGuido España, T Alex Perkins, Simon D Pollett, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Scientific Reports|August 31, 2021
A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemicSimon Pollett, Matthew A Conte, Mark Sanborn, et al.
Ebiomedicine|September 18, 2024
Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trialAnke Pagnon, Christophe Carre, Marion Aguirre, et al.
Vaccine|February 4, 2018
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristicsJohan Vekemans, Vasee Moorthy, Brigitta Giersing, et al.
Vaccines|July 27, 2024
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 TrialJuleen Gayed, Vishva Bangad, Xia Xu, et al.
Journal of Immunological Methods|October 6, 2020
A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulinsMélanie Merbah, Suzanne Wollen-Roberts, Zhanna Shubin, et al.
Emerging Infectious Diseases|July 21, 2016
Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015Jean-Louis Excler, Christopher J Delvecchio, Ryan E Wiley, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2020
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variantsBethany Dearlove, Eric Lewitus, Hongjun Bai, et al.
Journal of Virology|May 26, 2017
Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater <i>In Vivo</i> Protection than the Murine Precursor of PalivizumabMin Zhao, Zi-Zheng Zheng, Man Chen, et al.
Epidemics|June 2, 2023
Community incidence patterns drive the risk of SARS-CoV-2 outbreaks and alter intervention impacts in a high-risk institutional settingSean M Moore, Guido España, T Alex Perkins, et al.
Plos Computational Biology|October 7, 2022
Prioritizing interventions for preventing COVID-19 outbreaks in military basic trainingGuido España, T Alex Perkins, Simon D Pollett, et al.
Pageof 14